Ulsan, South Korea

Ii Shin Kim


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ii Shin Kim in Cancer Research

Introduction

Ii Shin Kim is a notable inventor based in Ulsan, South Korea. He has made significant contributions to the field of cancer research through his innovative work on DNA aptamers. His research focuses on developing compositions that can effectively inhibit cancer and its metastasis.

Latest Patents

Ii Shin Kim holds a patent for an "Aptamer for periostin and anti-cancer composition including same." This patent discloses a DNA aptamer that specifically binds to periostin, a protein associated with cancer. The composition aims to inhibit cancer and cancer metastasis, as well as serve as a diagnostic tool for these conditions. The aptamer's unique binding mechanism differentiates it from existing antibodies, potentially leading to more effective cancer treatment and diagnosis.

Career Highlights

Throughout his career, Ii Shin Kim has been associated with prestigious institutions such as the Ulsan National Institute of Science and Technology and the POSTECH Academy-Industry Foundation. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Ii Shin Kim has collaborated with notable colleagues, including Pann-Ghill Suh and Yu Jin Lee. These partnerships have further enriched his research endeavors and have played a crucial role in the development of his innovative solutions.

Conclusion

Ii Shin Kim's contributions to cancer research through his patented innovations highlight the importance of scientific advancements in combating this disease. His work exemplifies the potential of DNA aptamers in medical applications, paving the way for future breakthroughs in cancer treatment and diagnosis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…